The study of molecular and gene analysis and bone metabolism-improving effect of propiomibacterium freudenreichii milk whey culture against osteoporosis.
费氏丙酸杆菌乳清培养物抗骨质疏松的分子基因分析及骨代谢改善作用研究
基本信息
- 批准号:17390538
- 负责人:
- 金额:$ 10.05万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2005
- 资助国家:日本
- 起止时间:2005 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
To see the relationship between immune cell and osteoporosis occurrence by immunosuppresant, we have established the osteoporosis mouse model using immunosuppresant (FK506) injected nude mouse and wild type mouse. The results of wild type were amount of trabecula bone under enchondral ossification was decreased, and number of osteoclast, TRAP positive, was obviously increased in enchondral ossification. On the other hand, there was almost no bone resorption under enchondral ossification in the nude mouse' s result. Those results suggest that immune cell contributes to the osteoporosis occurrence by the immunosuppresant. We have found propiomibacterium freudenreichii milk whey culture (PC), starter of Swiss cheese, could rescue osteoporosis in our model. In further experiment, PC could inhibit the differentiation of osteoclast and prevent osteoporosis. But it is hard to simply say that PC rescued osteoporosis in our model by differential inhibition of osteoclast, because of the osteocla … More st differentiation and immune system participation. To see the details, we have gotten the following results, a) The number of osteoclast was significantly increased in the mouse osteoblast-like stroma cell and osteoblast mixed culture with supplementation of CD4 positive T-cell or B220 positive B-cell, extracted from bone marrow with magnet beads. b) FACS result was the immunosuppresant decreased the number of T-cell and increased the number of B-cell in spleen and mesentericlymph node of our model, c) DHNA, contained in PC, has naphthoquinone. The basic skeleton is the same as vitamin K2, which is a research attention of bone mass recovery in recent years. DHNA made the same results as PC's and was identified as a factor of inhibitory effect of bone resorption.We elucidated the bone mass recovery with DHNA, and the relationship immune system and osteoclast. Furthermore, to identify osteoporosis-related gene, we have seen the alteration of gene expression in'bone marrow with DNA microarray. Less
为了了解免疫抑制剂与骨质疏松发生的关系,我们采用免疫抑制剂FK506注射裸鼠和野生型小鼠建立骨质疏松小鼠模型。野生型软骨成骨时骨小梁数量减少,软骨成骨时TRAP阳性破骨细胞数量明显增加。另一方面,裸鼠内软骨成骨后几乎没有骨吸收。提示免疫细胞通过免疫抑制剂参与骨质疏松的发生。我们发现瑞士奶酪发酵剂丙杆菌乳清培养物(PC)可以挽救我们模型中的骨质疏松症。在进一步的实验中,PC可以抑制破骨细胞的分化,预防骨质疏松。但很难简单地说,在我们的模型中,PC通过对破骨细胞的差异抑制来拯救骨质疏松症,因为破骨细胞有更多的分化和免疫系统参与。具体来看,我们得到了以下结果:a)用磁珠提取骨髓,添加CD4阳性t细胞或B220阳性b细胞的小鼠成骨样基质细胞和成骨细胞混合培养中,破骨细胞的数量明显增加。b) FACS结果显示免疫抑制剂可使模型脾和肠系膜淋巴结t细胞数量减少,b细胞数量增加;c) PC中含有萘醌类dna。基本骨架与维生素K2相同,是近年来骨量恢复的研究热点。dna与PC的结果相同,被认为是抑制骨吸收的一个因素。我们阐明了dna对骨量恢复的影响,以及免疫系统与破骨细胞的关系。此外,为了鉴定骨质疏松相关基因,我们用DNA芯片观察了骨髓中基因表达的改变。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
子どもは素晴らしい(お父さんとお母さんの子育てのために)
孩子们很棒(对于养育孩子的爸爸妈妈来说)
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Shigeru;Maeda;Ichiro;Nakatsuka;Takuya;Miyawaki;Takuo;Kuboki;Masahiko;Shimada;Takashi Fujii;Tomohiro Yamada;Toshio Sugahara;Takaaki Ueno;Seiji Kondo;Seiji Kondo;Mishima K;Fujii T;Yamada T;Hitoshi Nagatsuka;Hitoshi Nagatsuka;菅原 利夫 共著
- 通讯作者:菅原 利夫 共著
Various immunostaining patterns of CD31, CD34 and endoglin and their relationship with lymph node metastasis in oral squamous cell carcinomas
- DOI:10.1111/j.1600-0714.2004.00227.x
- 发表时间:2005-02-01
- 期刊:
- 影响因子:3.3
- 作者:Nagatsuka, H;Hibi, K;Nagai, N
- 通讯作者:Nagai, N
子どもは素晴らしい (お父さんとお母さんの子育てのために)
孩子们很精彩(因为爸爸妈妈的养育)
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Shigeru;Maeda;Ichiro;Nakatsuka;Takuya;Miyawaki;Takuo;Kuboki;Masahiko;Shimada;Takashi Fujii;Tomohiro Yamada;Toshio Sugahara;Takaaki Ueno;Seiji Kondo;Seiji Kondo;Mishima K;Fujii T;Yamada T;Hitoshi Nagatsuka;Hitoshi Nagatsuka;菅原 利夫 共著;菅原 利夫 共著
- 通讯作者:菅原 利夫 共著
Expression of transcription factor Sox9 in the cartilage formation from grafted periosteal cells.
转录因子 Sox9 在移植骨膜细胞软骨形成中的表达。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Satoru;Sakurai;Atsuo;F.;Fukunaga,Takuya;Miyawaki;Tatsuya;Ichinohe;Yuzuru;KanekoCalifornia;USA;Takaaki Ueno
- 通讯作者:Takaaki Ueno
Novel angiogenic inhibitor DN-9693 that inhibits Past-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial grow factor (VEGF) in human endothelial cells.
新型血管生成抑制剂 DN-9693 可抑制人内皮细胞中血管内皮生长因子 (VEGF) 对结缔组织生长因子 (CTGF/CCN2) 的转录诱导。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Shigeru;Maeda;Ichiro;Nakatsuka;Takuya;Miyawaki;Takuo;Kuboki;Masahiko;Shimada;Takashi Fujii;Tomohiro Yamada;Toshio Sugahara;Takaaki Ueno;Seiji Kondo;Seiji Kondo
- 通讯作者:Seiji Kondo
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SUGAHARA Toshio其他文献
SUGAHARA Toshio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SUGAHARA Toshio', 18)}}的其他基金
Research on metabolic mechanism of palatal processes and cleft palate onset mechanism from genes
从基因角度研究腭突代谢机制及腭裂发病机制
- 批准号:
16K11772 - 财政年份:2016
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Localization of Perlecan and Heparanase in the Epithelial
基底膜聚糖和乙酰肝素酶在上皮细胞中的定位
- 批准号:
22592269 - 财政年份:2010
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular and genetic analysis of osteoclast differentiantion factor and osteoclastgenesis inhibitory factor in osteoporosis and control of inhibition of bone resorption by 1, 4-dihydroxy-2-naphthoic acid(DHNA)
破骨细胞分化因子和破骨细胞生成抑制因子在骨质疏松症中的分子和遗传学分析及1, 4-二羟基-2-萘甲酸(DHNA)抑制骨吸收的控制
- 批准号:
19390516 - 财政年份:2007
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecule gene analysis of bone absorption in bone reproduction medical care and development of bone absorption restraint medicine
骨再生医疗中骨吸收的分子基因分析及骨吸收抑制药物的开发
- 批准号:
15390614 - 财政年份:2003
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
A design and manufacture using CAD and CAE system, and its clinical application
利用CAD和CAE系统设计制造及其临床应用
- 批准号:
13470435 - 财政年份:2001
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinical application of our developed artificial temporomandibular joint. 1)study on respiratory function, especially sleep apnea syndrome, 2)study on jaw movement
我们研制的人工颞下颌关节的临床应用。
- 批准号:
10470433 - 财政年份:1998
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
THE STUDY OF A JAW MOVEMENT BEFORE AND AFTER TOTAL TMJ REPLACEMENT
全颞下颌关节置换术前后下颌运动的研究
- 批准号:
08457548 - 财政年份:1996
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a simulator for educational oral surgery using virtual reality
使用虚拟现实开发口腔外科教育模拟器
- 批准号:
08557115 - 财政年份:1996
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Development of artificial tempolomandibular joint
人工颞下颌关节的研制
- 批准号:
05557090 - 财政年份:1993
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
Investigation into Pre and Post Operative Functional Changes of Jaw Movement and Oral Cavity Related Muscles of Maxillofacial Deformaties.
颌面畸形下颌运动和口腔相关肌肉手术前后功能变化的调查。
- 批准号:
04454501 - 财政年份:1992
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似国自然基金
基于“化痰散结”理论的蚕梅方通过Bifidobacteria菌群激活cGAS-STING通路触发免疫反应防治肠道腺瘤癌变的机制研究
- 批准号:82305165
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Understanding the Intestinal Survival Strategy of Altruistic Bifidobacteria by Human Glycan Binding from the Molecular Structure
从分子结构了解利他双歧杆菌通过人类聚糖结合的肠道生存策略
- 批准号:
23H00322 - 财政年份:2023
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Probiotic bifidobacteria as a promising therapy to mitigate uremic toxin accumulation in chronic kidney disease
益生菌双歧杆菌是减轻慢性肾病尿毒症毒素积累的有前途的疗法
- 批准号:
449824 - 财政年份:2020
- 资助金额:
$ 10.05万 - 项目类别:
Studentship Programs
Elucidation of sulfur-assimilation mechanism in bifidobacteria
双歧杆菌硫同化机制的阐明
- 批准号:
20K05801 - 财政年份:2020
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Elucidation of the gene expression profile of bifidobacteria in the gut microbiota: development of selective recovery method
阐明肠道微生物群中双歧杆菌的基因表达谱:开发选择性恢复方法
- 批准号:
20H02893 - 财政年份:2020
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of Functional Extracellular Vesicles Based on the Glucose Metabolism Mechanism of Bifidobacteria and Their Application to Cancer Immunotherapy
基于双歧杆菌葡萄糖代谢机制的功能性细胞外囊泡的研制及其在癌症免疫治疗中的应用
- 批准号:
20K20205 - 财政年份:2020
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Effects of sulfomucin-binding bifidobacteria on intestinal barrier function and analysis of gut colonization mechanisms
磺粘蛋白结合双歧杆菌对肠道屏障功能的影响及肠道定植机制分析
- 批准号:
19K06374 - 财政年份:2019
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The development of the drug delivery system via recombinant bifidobacteria aiming for an anti-cancer TNF-alpha preparation without adverse side effects.
通过重组双歧杆菌开发药物输送系统,旨在开发无不良副作用的抗癌 TNF-α 制剂。
- 批准号:
19K07172 - 财政年份:2019
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The application of the drug delivery system by recombinant bifidobacteria to overcome the weak point of the low-molecule anticancer STAT3 inhibitors.
应用重组双歧杆菌给药系统克服小分子抗癌STAT3抑制剂的弱点。
- 批准号:
18K06755 - 财政年份:2018
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Sugar utilization strategy of bifidobacteria that supports the symbiosis with their hosts
支持与宿主共生的双歧杆菌糖利用策略
- 批准号:
18K14379 - 财政年份:2018
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Randomized double-blind comparative study on the effect of bifidobacteria on the induction of tolerance to egg allergy oral immunotherapy
双歧杆菌诱导鸡蛋过敏口服免疫疗法耐受作用的随机双盲比较研究
- 批准号:
18K05523 - 财政年份:2018
- 资助金额:
$ 10.05万 - 项目类别:
Grant-in-Aid for Scientific Research (C)